Back to results
US 2010/0303926 A1Published application
Organic compounds
AssigneeNovartis AG
InventorsPeter Herold, Stjepan Jelakovic, Robert Mah, Vincenzo Tschinke
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which in which R1 has the meaning explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.
Claims12
A compound of the formula
- its prodrug, its nitosated or nitrate ester derivative or its pharmaceutically acceptable salt, in which
- R1 is C1-8-alkanoyloxy, C1-8-alkanoyloxy-C1-8-alkyl, C1-8-alkoxy, C1-8-alkoxy-C1-8-alkoxy, C1-8-alkoxy-C1-8-alkoxy-C1-8-alkyl, C1-8-alkoxy-C1-8-alkyl, C1-8-alkoxycarbonylamino, C1-8-alkoxycarbonylamino-C1-8-alkyl, C0-8-alkylcarbonylamino, C0-8-alkylcarbonylamino-C1-8-alkyl, O—C1-8-alkylated carboxyl, O—C1-8-alkylated carboxyl-C1-8-alkyl, optionally N-mono- or N,N-di-C1-8-alkylated amino, optionally N-mono- or N,N-di-C1-8-alkylated amino-C1-8-alkyl, optionally N-mono- or N,N-di-C1-8-alkylated amino-carbonylamino, optionally N-mono- or N,N-di-C1-8-alkylated amino-carbonylamino-C1-8-alkyl, heterocyclyl, heterocyclyl-C1-8-alkyl, heterocyclyl-C0-8-alkyl-carbonyl-C0-8-alkylamino, heterocyclyl-C0-8-alkyl-carbonyl-C0-8-alkylamino-C1-8-alkyl, heterocyclyl-C0-8-alkyl-carbonyl-C1-8-alkyl, cycloalkyl-C0-8-alkyl-carbonyl-C0-8-alkylamino, cycloalkyl-C0-8-alkyl-carbonyl-C0-8-alkylamino-C1-8-alkyl, hydroxyl, hydroxy substituted C1-8-alkyl, optionally N-mono-, -di- or -tri-C1-8-alkylated or heterocyclyl-substituted ureido, or optionally N-mono-, -di- or -tri-C1-8-alkylated or heterocyclyl-substituted ureido-C1-8-alkyl and whereby the heterocyclyl and cycloalkyl radicals mentioned hereinbefore are unsubstituted or substituted.
The compound:
- (3S,4R,5R)-4-[4-((R)-2-Ethoxy-propoxymethyl)-phenyl]-3-hydroxymethyl-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]piperidine-1-carboxylic acid tert-butyl ester, or a pharmaceutically acceptable salt thereof.
The compound:
- (R)-2-Ethoxy-propan-1-ol.
Dependencies are inferred from the claim text.